S

Sheffield Children's NHS Foundation Trust | Sheffield Children's Hospital - Clinical Research Facility

Research site
(Unclaimed)
Location
Sheffield Children's Hospital, Sheffield, Sheffield, England
Site insights

Top conditions

Tuberous Sclerosis (1 trial)

Eczema (1 trial)

Dermatitis (1 trial)

Osteogenesis Imperfecta (1 trial)

Sclerosis (1 trial)

Top treatments

PF-04965842
Epidiolex

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 3
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex (EpiCom)

The purpose of this study is to investigate behavioral and other co-occurring outcomes with EPID(I/Y)OLEX as an add-on therapy in participants aged 1...

Enrolling
Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
Drug: Cannabidiol Oral Solution [Epidiolex]

The primary objectives of the study are to identify a setrusumab dosing strategy in participants with OI and to evaluate the effect of setrusumab vs...

Enrolling
Osteogenesis Imperfecta
Other: Placebo
Biological: Setrusumab
Locations recently updated

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 100 mg
Drug: Placebo

Trial sponsors

Jazz Pharmaceuticals logo

Jazz Pharmaceuticals (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems